Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape DOI Creative Commons
Qinghua Wu, You Li, Eugenie Nepovimová

et al.

Journal of Hematology & Oncology, Journal Year: 2022, Volume and Issue: 15(1)

Published: June 3, 2022

Hypoxia, a common feature of the tumor microenvironment in various types cancers, weakens cytotoxic T cell function and causes recruitment regulatory cells, thereby reducing tumoral immunogenicity. Studies have demonstrated that hypoxia hypoxia-inducible factors (HIFs) 1 2 alpha (HIF1A HIF2A) are involved immune escape. Under hypoxia, activation HIF1A induces series signaling events, including through programmed death receptor-1/programmed ligand-1. Moreover, triggers shedding complex class I chain-associated molecules nitric oxide impairment to disrupt surveillance by natural killer cells. The HIF-1-galactose-3-O-sulfotransferase 1-sulfatide axis enhances escape via increased cell-platelet binding. HIF2A upregulates stem factor expression recruit tumor-infiltrating mast cells increase levels cytokines interleukin-10 transforming growth factor-β, resulting an immunosuppressive microenvironment. Additionally, tumor-associated long noncoding RNAs suppresses function, enabling Overall, elucidating underlying mechanisms which HIFs promote evasion will allow for targeting HIF treatment. This review discusses current knowledge how facilitate escape, with evidence date implicating as molecular target such provides further insight into mechanism strategies immunotherapy suggested.

Language: Английский

The evolving translational potential of small extracellular vesicles in cancer DOI
Andreas Möller, Richard J. Lobb

Nature reviews. Cancer, Journal Year: 2020, Volume and Issue: 20(12), P. 697 - 709

Published: Sept. 21, 2020

Language: Английский

Citations

426

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond DOI
Luoyan Ai, Antao Xu, Jie Xu

et al.

Advances in experimental medicine and biology, Journal Year: 2020, Volume and Issue: unknown, P. 33 - 59

Published: Jan. 1, 2020

Language: Английский

Citations

386

The foundations of immune checkpoint blockade and the ipilimumab approval decennial DOI
Alan J. Korman, Sarah C. Garrett-Thomson, Nils Lönberg

et al.

Nature Reviews Drug Discovery, Journal Year: 2021, Volume and Issue: 21(7), P. 509 - 528

Published: Dec. 22, 2021

Language: Английский

Citations

376

Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming DOI Creative Commons
Samantha M. Morrissey, Fan Zhang, Chuanlin Ding

et al.

Cell Metabolism, Journal Year: 2021, Volume and Issue: 33(10), P. 2040 - 2058.e10

Published: Sept. 23, 2021

One of the defining characteristics a pre-metastatic niche, fundamental requirement for primary tumor metastasis, is infiltration immunosuppressive macrophages. How these macrophages acquire their phenotype remains largely unexplored. Here, we demonstrate that tumor-derived exosomes (TDEs) polarize toward an characterized by increased PD-L1 expression through NF-kB-dependent, glycolytic-dominant metabolic reprogramming. TDE signaling TLR2 and NF-κB leads to glucose uptake. TDEs also stimulate elevated NOS2, which inhibits mitochondrial oxidative phosphorylation resulting in conversion pyruvate lactate. Lactate feeds back on NF-κB, further increasing PD-L1. Analysis metastasis-negative lymph nodes non-small-cell lung cancer patients revealed macrophage positively correlates with levels GLUT-1 vesicle release gene YKT6 from tumors. Collectively, our study provides novel mechanism within niche identifies important link among exosomes, metabolism, metastasis.

Language: Английский

Citations

375

The biology, function, and applications of exosomes in cancer DOI Creative Commons
Jinyi Liu,

Liwen Ren,

Sha Li

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2021, Volume and Issue: 11(9), P. 2783 - 2797

Published: Jan. 10, 2021

Exosomes are cell-derived nanovesicles with diameters from 30 to 150 nm, released upon fusion of multivesicular bodies the cell surface. They can transport nucleic acids, proteins, and lipids for intercellular communication activate signaling pathways in target cells. In cancers, exosomes may participate growth metastasis tumors by regulating immune response, blocking epithelial-mesenchymal transition, promoting angiogenesis. also involved development resistance chemotherapeutic drugs. liquid biopsies be used as non-invasive biomarkers early detection diagnosis cancers. Because their amphipathic structure, natural drug delivery vehicles cancer therapy.

Language: Английский

Citations

372

Isolation and characterization of exosomes for cancer research DOI Creative Commons
Le Zhu, Haoting Sun, Shun Wang

et al.

Journal of Hematology & Oncology, Journal Year: 2020, Volume and Issue: 13(1)

Published: Nov. 10, 2020

Abstract Exosomes are a subset of extracellular vesicles that carry specific combinations proteins, nucleic acids, metabolites, and lipids. Mounting evidence suggests exosomes participate in intercellular communication act as important molecular vehicles the regulation numerous physiological pathological processes, including cancer development. released by various cell types under both normal conditions, they can be found multiple bodily fluids. Moreover, carrying wide variety macromolecules provide window into altered cellular or tissue states. Their presence biological fluids renders them an attractive, minimally invasive approach for liquid biopsies with potential biomarkers diagnosis, prediction, surveillance. Due to their biocompatibility low immunogenicity cytotoxicity, have clinical applications development innovative therapeutic approaches. Here, we summarize recent advances technologies exosome isolation research. We outline functions regulating tumor metastasis, drug resistance, immune modulation context Finally, discuss prospects challenges exosome-based therapeutics.

Language: Английский

Citations

357

Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer DOI Creative Commons
Hao Zhang, Ziyu Dai,

Wantao Wu

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2021, Volume and Issue: 40(1)

Published: June 4, 2021

Abstract The cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4)/B7 and programmed death 1 (PD-1)/ cell death-ligand (PD-L1) are two most representative immune checkpoint pathways, which negatively regulate T function during different phases of T-cell activation. Inhibitors targeting CTLA-4/B7 PD1/PD-L1 pathways have revolutionized immunotherapies for numerous cancer types. Although the combined anti-CTLA-4/B7 anti-PD1/PD-L1 therapy has demonstrated promising clinical efficacy, only a small percentage patients receiving or experienced prolonged survival. Regulation expression PD-L1 CTLA-4 significantly impacts treatment effect. Understanding in-depth mechanisms interplays could help identify with better immunotherapy responses promote their care. In this review, regulation is discussed at levels DNA, RNA, proteins, as well indirect biomarkers, localization within cell, drugs. Specifically, some potential drugs been developed to expressions high efficiency.

Language: Английский

Citations

353

Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine DOI Creative Commons
Mangesh Dattu Hade, Caitlin N. Suire, Zucai Suo

et al.

Cells, Journal Year: 2021, Volume and Issue: 10(8), P. 1959 - 1959

Published: Aug. 1, 2021

Exosomes are a type of extracellular vesicles, produced within multivesicular bodies, that then released into the space through merging body with plasma membrane. These vesicles secreted by almost all cell types to aid in vast array cellular functions, including intercellular communication, differentiation and proliferation, angiogenesis, stress response, immune signaling. This ability contribute several distinct processes is due complexity exosomes, as they carry multitude signaling moieties, proteins, lipids, surface receptors, enzymes, cytokines, transcription factors, nucleic acids. The favorable biological properties exosomes biocompatibility, stability, low toxicity, proficient exchange molecular cargos make prime candidates for tissue engineering regenerative medicine. Exploring functions payloads can facilitate regeneration therapies provide mechanistic insight paracrine modulation activities. In this review, we summarize current knowledge exosome biogenesis, composition, isolation methods. We also discuss emerging healing exosomal cargos, such microRNAs, brain injuries, cardiovascular disease, COVID-19 amongst others. Overall, review highlights burgeoning roles potential applications

Language: Английский

Citations

348

Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer DOI Creative Commons
Qingfang Han, Wenjia Li, Kaishun Hu

et al.

Molecular Cancer, Journal Year: 2022, Volume and Issue: 21(1)

Published: Nov. 1, 2022

Abstract Exosomes are well-known key mediators of intercellular communication and contribute to various physiological pathological processes. Their biogenesis involves four steps, including cargo sorting, MVB formation maturation, transport MVBs, fusion with the plasma membrane. Each process is modulated through competition or coordination multiple mechanisms, whereby diverse repertoires molecular cargos sorted into distinct subpopulations exosomes, resulting in high heterogeneity exosomes. Intriguingly, cancer cells exploit strategies, such as aberrant gene expression, posttranslational modifications, altered signaling pathways, regulate biogenesis, composition, eventually functions exosomes promote progression. Therefore, exosome biogenesis-targeted therapy being actively explored. In this review, we systematically summarize recent progress understanding machinery how it regulated context cancer. particular, highlight pharmacological targeting a promising therapeutic strategy.

Language: Английский

Citations

345

Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics DOI
Hirohito Yamaguchi, Jung-Mao Hsu, Wenhao Yang

et al.

Nature Reviews Clinical Oncology, Journal Year: 2022, Volume and Issue: 19(5), P. 287 - 305

Published: Feb. 7, 2022

Language: Английский

Citations

331